TY  - GEN 
AU  - Martínez-Cuadrón, D.
AU  - Megías-Vericat, J.E.
AU  - Gil, C.
AU  - Bernal, T.
AU  - Tormo, M.
AU  - Martínez-Sánchez, P.
AU  - Rodríguez-Medina, C.
AU  - Serrano, J.
AU  - Herrera, P.
AU  - Pérez Simón, J.A.
AU  - Sayas, M.J.
AU  - Bergua, J.
AU  - Lavilla Rubira, Esperanza
AU  - Amigo, M.L.
AU  - Benavente, C.
AU  - López Lorenzo, J.L.
AU  - Pérez Encinas, Manuel Mateo
AU  - Vidriales, M.B.
AU  - Colorado, M.
AU  - de Rueda, B.
AU  - García-Boyero, R.
AU  - Marini, S.
AU  - García-Suárez, J.
AU  - López-Pavía, M.
AU  - Gómez-Roncero, M.I.
AU  - Noriega Concepción, Victor
AU  - López, A.
AU  - Labrador, J.
AU  - Cabello, A.
AU  - Sossa, C.
AU  - Algarra, L.
AU  - Stevenazzi, M.
AU  - Solana-Altabella, A.
AU  - Boluda, B.
AU  - Montesinos, P.
PY  - 2024
SN  - 1592-8721
UR  - http://hdl.handle.net/20.500.11940/20371
AB  - Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AML-MRC) aged 60 to 75 years are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete remission with/without...
LA  - eng
KW  - Humans
KW  - Middle Aged
KW  - Aged
KW  - Retrospective Studies
KW  - Disease-Free Survival
KW  - Cytarabine
KW  - Leukemia, Myeloid, Acute
KW  - Remission Induction
KW  - Hematopoietic Stem Cell Transplantation
TI  - Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
DO  - 10.3324/HAEMATOL.2022.282506
KW  - HULA
KW  - AS Lugo AP
KW  - AS Santiago AP
KW  - CHUS
KW  - AS Coruña AP
KW  - CHUAC
KW  - INIBIC
VL  - 109
ER  -